Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: VIROVAX LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2018-09-30 to 2024-09-29
Current total value of award: $9273907
Description: ADJUVANT DEVELOPMENT PROGRAM